Table 2 Interviews with obstetric health care providers on the standard local care regarding HDP
From: Bottom-up development of national obstetric guidelines in middle-income country Suriname
Hypertensive disorders of pregnancy | n = 43 (100%) |
|---|---|
Definitions clear | |
 - Pre-eclampsia | 38 (88) |
 - Severe pre-eclampsia | 22 (51) |
 - Eclampsia | 34 (79) |
Anticipation / prevention | |
 - Risk factors known | 36 (84) |
 - Aspirine | 10 (23) |
 - Calcium | 22 (51) |
Oral medical treatment (1st line) | |
 1. Methyldopa | 43 (100) |
 2. Hydralazine | 43 (100) |
 3. Nifidipine (antepartum) | 5 (12) |
 4. Labetalol | 21 (48) |
Parenteral medical treatment (2nd line) | |
 1. Hydralazine (direct shots) | 43 (100) |
 2. Hydralazine (perfussor) | 25 (58) |
 3. Labetalol | 15 (35) |
 4. Ketanserin | 5 (12) |
Magnesium sulfate | |
 - Loading dose (4–6 g/30 min) | 26 (60) |
 - Maintanance dose (1 g/hr) | 43 (100) |
 - Initiation threshold: BP ≥110 | 32 (74) |
 - Duration: 24 – 48 hours | 43 (100) |
 - Repeat (2 g/5 min) in seizure | 6 (14) |
 - Diazepam before MgSO4 | 38 (88) |
Stabilization of severe PE / eclampsia | |
 - Minimum 48 hr before termination of pregnancy | 8 (19) |
Earliest termination in severe PE | |
 - GA ≥ 27 weeks | 23 (53) |
 - GA ≥ 30 weeks | 15 (35) |
 - GA ≥ 32 weeks | 5 (12) |
Other | |
 - Eclampsia box availablea | 9 (21) |
 - Oxygen during eclampsia | 12 (28) |
 - Two i.v. access lines | 22 (51) |
 - i.v. loading fluid before MgSO4 | 7 (16) |
 - Restrict fluids to < 2 L / 24 hrs | 0 (0) |
 - Early warning score (MEOWS) | 7 (16) |